AstraZeneca doubles down on COPD awareness efforts during national awareness month
More than half of people living with chronic obstructive pulmonary disease in the US are undiagnosed. It’s not a brand new problem, but it’s one AstraZeneca is shining a light on with marketing and awareness efforts during November’s National COPD Awareness Month.
AZ physician partner nd leading pulmonologist MeiLan Han is lending her expertise to its effort and speaking out about the challenges and stigma of COPD.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,500+ biopharma pros reading Endpoints daily — and it's free.